EFFICACY OF ANTENATAL BETAMETHASONE THERAPY ON MATERNAL BLOOD GLUCOSE LEVELS
DOI:
https://doi.org/10.56802/wbpye872Keywords:
Betamethasone, glycemic profile, neonatal respiratory distress syndrome, postprandial blood glucoseAbstract
Background: It has been noted that giving pregnant women betamethasone reduces the frequency and severity of
newborn respiratory distress syndrome. Blood glucose levels temporarily rise as a result of the placenta's insulin resistance
and diabetogenic potential.
Aim: Assessing the impact of prenatal betamethasone therapy on maternal blood glucose levels during preterm pregnancy
was the goal of the current investigation.
Methods: 280 pregnant women without diabetes who showed signs of giving birth before 34+6 weeks gestation and had
one or two betamethasone doses were evaluated for this research. Every day, a POC (point of care) device was used to
measure capillary blood glucose levels in order to evaluate the glycemic profile in pregnant women. During their
evaluation, a healthy food was provided to all girls.
